Paricalcitol NDC 16729-310

NDC codes

FDA NDC Directory

Product NDC (as listed)16729-310Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16729-0310Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16729-310-08	16729031008	25 VIAL, SINGLE-DOSE in 1 CARTON (16729-310-08) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Mar 24, 2016
16729-310-63	16729031063	1 VIAL, SINGLE-DOSE in 1 CARTON (16729-310-63) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Mar 24, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Paricalcitol
Generic name (nonproprietary): paricalcitol
Active ingredients: Paricalcitol — 2 ug/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Accord Healthcare, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 207174
Marketing start: Mar 24, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Ergocalciferols (Chemical structure)
Identifiers: Product ID 16729-310_1e7e9c4e-79dd-a776-e063-6394a90a43a1SPL ID 1e7e9c4e-79dd-a776-e063-6394a90a43a1SPL set ID 2b7c7587-2042-0d9c-e054-00144ff88e88RxCUI 200321, 1736919, 1736931UNII 6702D36OG5UPC 0316729310635, 0316729311304, 0316729311632, 0316729311083
Pharmacologic class: Vitamin D Analog; Vitamin D2 Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N416729031008 followed by a unit qualifier and the quantity

Package 16729-0310-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 30, 2024.

Indications (excerpt from the label)

Paricalcitol Injection is indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease (CKD) on dialysis. Paricalcitol Injection is a vitamin D analog indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease on dialysis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 207174

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 207174
Product	Strength	Form · route	Labeler	Product NDC
Paricalcitol	Paricalcitol 5 ug/mL	Injection, SolutionIntravenous	Accord Healthcare, Inc.	16729-311